ELDN Operating Income Growth
Eledon Pharmaceuticals Inc · Operating Income Growth
ELDN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported3.75%period ending
ELDN TTM Operating Income YoY % (-77.58% → 3.75%)
Year-over-year change
High-resolution chart · PNG
ELDN operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 3.753% | |
| -11.3245% | |
| -17.9577% | |
| -53.7968% | |
| -87.3985% | |
| -81.6506% | |
| -64.1326% | |
| 38.4576% | |
| 48.3118% | |
| 52.3199% | |
| 51.3729% | |
| -133.4824% | |
| -132.4956% | |
| -137.7429% | |
| -139.8568% | |
| -15.6518% | |
| -32.441% | |
| -56.5706% | |
| -99.6588% | |
| -107.7499% | |
| -125.7353% | |
| -65.5352% | |
| -15.0396% | |
| 1.0753% | |
| 23.3803% | |
| 9.8265% | |
| -14.1607% | |
| -42.0521% | |
| -54.1523% | |
| -11.0729% | |
| -7.1565% | |
| 21.5755% | |
| 17.6795% | |
| -88.8615% | |
| 26.2409% | |
| 41.1338% | |
| 62.0582% | |
| 82.2886% | |
| 60.6968% | |
| 37.9456% | |
| -1.2126% | |
| -36.3069% | |
| -92.9119% | |
| -77.8022% | |
| -77.5786% |